Coprolalia has been a recognized symptom of Tourette syndrome from the
first description of the syndrome. Copropraxia is seen less frequentl
y and almost always occurs in association with coprolalia. Prevalence
of coprolalia varies from 8% in primary pediatric practices to over 60
% in tertiary referral centers. Coprolalia tends to peak in severity d
uring adolescence and to wane during adulthood. The pathogenesis may b
e related to dysfunction of basal ganglionic and limbic mini-circuits.
Coprolalia has also been seen in a variety of other neurologic disord
ers. Treatment is primarily pharmacologic with dopamine-blocking agent
s.